Peanuts and Glycemic Control

Completed · Phase 2

Conditions studied: Type2 Diabetes, Cardiovascular Diseases

In brief

A two-period randomized crossover study will be conducted to determine the effect of peanuts on glycemic control, and elucidate the role of the microbiome in glucose regulation, in individuals with impaired fasting glucose.

Key facts

Study ID

NCT03654651

Run by

Penn State University

People needed

51

Starts

2018-10-01

Expected to finish

2019-12-20

Last updated by the study team

2023-08-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Non-smoking
• Impaired fasting glucose at screening (≥ 100 mg/dL).
• BMI ≥20 and ≤40 kg/m2.

You may not qualify if…

• Diagnosed diabetes or fasting glucose >126 mg/dl
• Systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)
• Prescribed anti-hypertensive, lipid lowering or glucose lowering drugs
• Established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease or inflammatory conditions
• Use of supplements (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals and not willing to cease for the duration of the study
• Pregnancy or lactation
• Weight loss of >=10% of body weight within the 6 months prior to enrolling in the study
• Smoking or use of any tobacco products
• Allergy to test foods
• Consumption of >14 alcoholic drinks/week

Where it is running

• Pennsylvania State University — University Park, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.